Skip to content
-
Get Breaking News Alerts
Subscribe to SRKANALYTICS.COM Push Notifications and never miss important updates.
SRK Analytics SRK Analytics

Money Roar

  • Home
  • Business Insights
  • Market
  • Startup
  • Emerging Market
  • IPOs
  • Corporate Updates
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Respiratory Care

  • Home
  • Respiratory Care
Cipla Secures US FDA Approval for Generic Advair Diskus Across All Strengths
Posted inBusiness Insights

Cipla Secures US FDA Approval for Generic Advair Diskus Across All Strengths

Indian pharmaceutical major Cipla Limited has secured final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for generic Advair Diskus. The regulatory clearance…
Posted by Prasenjit Bhowmik July 28, 2026

Recent Posts

  • US Treasuries Rally as Falling Oil Prices and Paused Geopolitical Strikes Attract Buyers Before Fed Meeting
  • Cipla Secures US FDA Approval for Generic Advair Diskus Across All Strengths
  • Starbucks Abandons AI Inventory Tool, Leaving Tech Partner Blindsided
  • JetBlue Overhauls Economy Class Tiers and Retires Legacy ‘Core’ Fare Option
  • Prime Minister Modi Meets Skyroot Founders Following Vikram-1 Milestone, Highlighting India’s Private Space Sector

Recent Comments

No comments to show.

Archives

  • July 2026
  • June 2026

Categories

  • Business Insights
  • Corporate Updates
  • Economy
  • Emerging Market
  • Market
  • Startup
July 2026
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728293031 
« Jun    
Copyright 2026 — SRK Analytics. All rights reserved.
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Contact Us
  • About Us
Scroll to Top
Follow by Email
Facebook
fb-share-icon
X (Twitter)
Post on X
LinkedIn
Share
Instagram
Telegram
WhatsApp
THREADS

Website security powered by MilesWeb